Showing results (231-240 of 255) with videos related to
Sort By:
Pageof 26
The American Journal of Physiology|December 1, 1987
Atrial natriuretic peptide transcription, storage, and release in rats with myocardial infarctionR E Mendez, J M Pfeffer, F V Ortola, et al.Clinical Science (London, England : 1979)|December 2, 2000
Increased gene expression of adrenomedullin and adrenomedullin-receptor complexes, receptor-activity modifying protein (RAMP)2 and calcitonin-receptor-like receptor (CRLR) in the hearts of rats with congestive heart failureK Totsune, K Takahashi, H S Mackenzie, et al.Proceedings of the National Academy of Sciences of the United States of America|April 1, 1993
Primary structure and functional expression of a cDNA encoding the thiazide-sensitive, electroneutral sodium-chloride cotransporterG Gamba, S N Saltzberg, M Lombardi, et al.Kidney International|September 1, 1999
Renin-angiotensin blockade lowers MCP-1 expression in diabetic ratsS Kato, V A Luyckx, M Ots, et al.Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|March 11, 1998
Candesartan cilexetil reduces chronic renal allograft injury in Fisher-->Lewis ratsH S Mackenzie, F Ziai, H Nagano, et al.Hepatology (Baltimore, Md.)|October 1, 1994
Renal effects of natriuretic peptide receptor blockade in cirrhotic rats with ascitesP Angeli, W Jiménez, V Arroyo, et al.The Journal of Clinical Investigation|January 1, 1983
Role for intrarenal mechanisms in the impaired salt excretion of experimental nephrotic syndromeI Ichikawa, H G Rennke, J R Hoyer, et al.Peptides|January 5, 2002
Adrenomedullin and its receptor complexes in remnant kidneys of rats with renal mass ablation: decreased expression of calcitonin receptor-like receptor and receptor-activity modifying protein-3K Totsune, K Takahashi, H S Mackenzie, et al.Journal of the American Society of Nephrology : JASN|October 1, 1994
HS-142-1, a potent antagonist of natriuretic peptides in vitro and in vivoP L Zhang, W Jiménez, H S Mackenzie, et al.Diabetologia|October 1, 2010
Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trialY Miao, D Dobre, H J Lambers Heerspink, et al.Pageof 26